About Hospital Universitario Virgen de la Arrixaca
El Hospital Clínico Universitario Virgen de la Arrixaca, es un complejo hospitalario público de Murcia, situado en la Avenida del Primero de Mayo, S/N, en la pedanía murciana de El Palmar. En la actualidad, se trata del mayor complejo hospitalario del Sistema Sanitario Público de Murcia.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Hospital Universitario Virgen de la Arrixaca
During the past decade, Hospital Universitario Virgen de la Arrixaca conducted 244 clinical trials. In the 10-year time frame, 244 clinical trials started and 62 clinical trials were completed, i.e. on
average, 25.4% percent of trials that started reached the finish line to date. In the past 5 years, 102 clinical trials started and 38 clinical trials were completed. i.e. 37.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
2004-04-01
2018-10-01
Completed
695
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
2004-02-01
2012-11-01
Completed
3,397
S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
2006-08-01
2016-02-01
Completed
1,038
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
2005-11-01
2018-01-01
Completed
2,334
Postoperative Chemotherapy With or Without Bevacizumab for Patients With Stage II or III Rectal Cancer
2006-02-17
2019-02-11
Terminated
355
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital Universitario Virgen de la Arrixaca" #1 sponsor was "Hoffmann-La Roche" with 27 trials, followed by "PETHEMA Foundation" with 16 trials
sponsored, "Pfizer" with 15 trials sponsored, "Spanish Breast Cancer Research Group" with 15 trials sponsored and "Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia"
with 15 trials sponsored. Other sponsors include 288 different institutions and
companies that sponsored additional 185 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario Virgen de la Arrixaca"
#1 collaborator was "Hospital Universitario Virgen de la Arrixaca" with 12 trials as a collaborator, "Instituto de Salud Carlos III" with 10 trials as a collaborator, "Hoffmann-La Roche" with 8 trials as a collaborator, "Pfizer" with 7 trials as a collaborator and "AstraZeneca" with 5 trials as a collaborator. Other collaborators include 260 different institutions and companies that were
collaborators in the rest 196 trials.
Clinical Trials Conditions at Hospital Universitario Virgen de la Arrixaca
According to Clinical.Site data, the most researched conditions in "Hospital Universitario Virgen de la Arrixaca" are
"Coronary Artery Disease" (20 trials), "Breast Cancer" (18 trials), "Heart Failure" (12 trials), "Cystic Fibrosis" (10 trials) and "Multiple Myeloma" (10 trials). Many other conditions were trialed in "Hospital Universitario Virgen de la Arrixaca" in a lesser frequency.
Clinical Trials Intervention Types at Hospital Universitario Virgen de la Arrixaca
Most popular intervention types in "Hospital Universitario Virgen de la Arrixaca" are "Drug" (231 trials), "Device" (38 trials), "Procedure" (33 trials), "Other" (31 trials) and "Biological" (24 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (38 trials), "Paclitaxel" (14 trials), "Cyclophosphamide" (11 trials), "Dexamethasone" (10 trials) and "ELX/TEZ/IVA" (9 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital Universitario Virgen de la Arrixaca
The vast majority of trials in "Hospital Universitario Virgen de la Arrixaca" are
328 trials for "All" genders, 42 trials for "Female" genders and 9 trials for "Male" genders.
Clinical Trials Status at Hospital Universitario Virgen de la Arrixaca
Currently, there are 155 active trials in "Hospital Universitario Virgen de la Arrixaca".
2 are not yet recruiting,
105 are recruiting,
45 are Active, not recruiting,
and 3 are Enrolling by invitation.
In total, there were 161 completed trials in Hospital Universitario Virgen de la Arrixaca,
1 suspended trials,
and 27 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitario Virgen de la Arrixaca, 22 "Phase 1"
clinical trials were conducted, 76 "Phase 2" clinical
trials and 133 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 32 trials, and there were
also 41 trials that are defined as “Not Applicable".